Serum-soluble interleukin-2 receptor con
β
Saburo Murakami; Akira Safomi; Kiyoshi Lshida; Hideaki Murai; Moriyuki Mafsuki;
π
Article
π
1994
π
John Wiley and Sons
π
English
β 369 KB
π 2 views
Background. Serum concentrations of soluble interleukin-2 receptor (IL-2R) were found to be high in patients with autoimmune diseases, lung cancer, malignant lymphoma, tuberculosis, and other diseases. Serum-soluble IL-2R was evaluated as a tumor maker in patients with gastric cancer. Methods. Preo